Soleno Therapeutics's total assets for Q4 2025 were $563.83M, a decrease of -6.01% from the previous quarter. SLNO total liabilities were $113.72M for the fiscal quarter, a 8.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.